Company: THC
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001193125-25-079143
Chunk: 24

Company: TENET HEALTHCARE CORP
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 24
---
 shareholders |

| • |     | Advocates on behalf of the Board in meetings with investors, legislators, regulators and other government officials |

| • |     | Serves an oversight role, in conjunction with the Governance Committee, in the Board performance evaluation process |

Senator Kerrey has participated in in-personengagement meetings with a number of our significant shareholders to discuss and seek feedback on various matters regarding the Company’s strategy and governance practices, establishing a direct line of communication between shareholders and independent members of our Board. Senator Kerrey shares the feedback with the full Board so that it may be incorporated into the Board’s decision-making processes. Board and Committee Organization and Responsibilities Board Meetings and Attendance We are governed by our Board. Members of our Board are kept informed of our business through discussions with our Chief Executive Officer and other senior officers, by reviewing materials provided to them, and by participating in meetings of the Board and its committees. Directors are also encouraged to attend continuing education courses relevant to their service on the Company’s Board. Significant business decisions are generally considered by the Board as a whole. The Board met six times during 2024. The independent directors of the Board, the Board and each committee of the Board frequently meet in executive sessions, including at least once during each regularly scheduled Board meeting. Each director who served during 2024 participated in at least 75% of the aggregate meetings of the Board and the committees on which he or she served during the period he or she served as a director and committee member. Board members are encouraged to attend our annual meeting of shareholders. Twelve directors were in attendance at the 2024 Annual Meeting.

| 2025 PROXY STATEMENT |     | 25 |

Corporate Governance and Board Practices Committees Tenet’s Board has four standing committees – Audit, HR, Governance and QCE – and one special committee – ESG. The following table identifies the current members of each of our committees.

| Director                    |     | Audit* |     | HR    |     | Governance |     | QCE   |     | ESG   |
| Vineeta Agarwala, M.D., PhD |     |        |     |       |     |            |     |       |     |       |
| James L. Bierman            |     |        |     |       |     |            |     | Chair |     |       |
| Roy Blunt                   |     |        |     |       |     |            |     |       |     |       |
| Richard W. Fisher           |